- Joined
- Dec 18, 2015
- Messages
- 3,216
- Reaction score
- 4,930
Hey a computer can do most of the contouring now? Why not. "Clinical grade" contouring?!
If you're getting paid the same or less with APM (especially for those irksome, zero-reimbursing retreats) the easiest way to boost your hourly pay is work less hours. Credit Palex on this one.
September 18, 2020
Limbus AI receives FDA clearance for Limbus Contour
Limbus AI announces 510(k) clearance from the U.S. Food and Drug Administration for Limbus Contour, the company’s artificial intelligence (AI) powered automatic contouring software. Limbus AI is focused on the development of products designed to improve efficiency in cancer diagnosis, treatment, and follow up. Their flagship product, Limbus Contour, is backed by comprehensive research and produces clinical grade contours that are revolutionizing the speed of planning radiation therapy treatments.
“With Limbus Contour, clinicians have significantly reduced contouring time, allowing them to dedicate more time to direct patient care. We believe our product will set the standard for AI based automatic contouring and dramatically improve the productivity in any radiotherapy department. The product shows expert level performance, is simple to use and integrates with any treatment planning platform.” - Dr. Joshua Giambattista, Medical Lead, Limbus AI.
510(k) clearance for Contour is a significant milestone for Limbus AI. The company will now be seeking to expand into the US market while continuing the development of additional AI contouring products. With an established network of international clinical partners and a growing list of peer reviewed research publications, Limbus AI is well positioned to develop, validate and market test new AI based products for cancer care.
If you're getting paid the same or less with APM (especially for those irksome, zero-reimbursing retreats) the easiest way to boost your hourly pay is work less hours. Credit Palex on this one.
September 18, 2020
Limbus AI receives FDA clearance for Limbus Contour
Limbus AI announces 510(k) clearance from the U.S. Food and Drug Administration for Limbus Contour, the company’s artificial intelligence (AI) powered automatic contouring software. Limbus AI is focused on the development of products designed to improve efficiency in cancer diagnosis, treatment, and follow up. Their flagship product, Limbus Contour, is backed by comprehensive research and produces clinical grade contours that are revolutionizing the speed of planning radiation therapy treatments.
“With Limbus Contour, clinicians have significantly reduced contouring time, allowing them to dedicate more time to direct patient care. We believe our product will set the standard for AI based automatic contouring and dramatically improve the productivity in any radiotherapy department. The product shows expert level performance, is simple to use and integrates with any treatment planning platform.” - Dr. Joshua Giambattista, Medical Lead, Limbus AI.
510(k) clearance for Contour is a significant milestone for Limbus AI. The company will now be seeking to expand into the US market while continuing the development of additional AI contouring products. With an established network of international clinical partners and a growing list of peer reviewed research publications, Limbus AI is well positioned to develop, validate and market test new AI based products for cancer care.